SCHEMBL26133885

SCHEMBL26133885

Cn1cc(-c2c(C3=CCC4(CCNCC4)CC3)n(C)c3ncnc(N)c23)cn1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 2/20 0.35
▸ JAK3 P52333 8/20 0.35
▸ JAK2 O60674 7/20 0.35
▸ JAK1 P23458 3/20 0.35
▸ LRRK2 Q5S007 3/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ TYK2 P29597 2/20 0.32
▸ BTK Q06187 2/20 0.32
▸ LCK P06239 1/20 0.32
▸ SRC P12931 1/20 0.32
▸ KCNH2 Q12809 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ PRKCQ Q04759 1/20 0.31
▸ MAP4K1 Q92918 1/20 0.31
▸ PRMT5 O14744 2/20 0.30
▸ METTL3 Q86U44 2/20 0.30
▸ EEF2K O00418 1/20 0.30
▸ FGR P09769 1/20 0.30
▸ EPHA1 P21709 1/20 0.30
▸ TXK P42681 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26106044 0.85 CCNT1 (0.38) RETLRRK2PIK3CDBTKLCK
SCHEMBL30582605 0.85 CCNT1 (0.38) RETLRRK2PIK3CDBTKLCK
SCHEMBL30582601 0.84 PIK3CD (0.40) RETLRRK2PIK3CDSRCFGR
SCHEMBL26105782 0.84 PIK3CD (0.40) RETLRRK2PIK3CDSRCFGR
SCHEMBL26105963 0.83 CCNT1 (0.34) RETLRRK2PIK3CDSRCPRMT5
SCHEMBL30582633 0.83 CCNT1 (0.34) LRRK2PIK3CDSRCFGREPHA1
SCHEMBL26106109 0.83 CCNT1 (0.34) LRRK2PIK3CDSRCFGREPHA1
SCHEMBL30582608 0.83 CCNT1 (0.34) RETLRRK2PIK3CDSRCPRMT5
SCHEMBL26107963 0.83 LRRK2 (0.34) RETLRRK2
SCHEMBL30582544 0.83 SRC (0.44) PIK3CDLCKSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4499616-A1 SPIROBICYCLIC COMPOUNDS Acerand Therapeutics (Hong Kong) Limited (HK) 2025-02-05 — — EP disclosed
CN-119013260-A Spirobicyclic compounds 优领医药科技(香港)有限公司 2024-11-22 — — CN disclosed
WO-2023192502-A1 SPIROBICYCLIC COMPOUNDS ACERAND THERAPEUTICS (USA) LIMITED (US) 2023-10-05 — — WO disclosed
Send feedback